Mechanisms of Action of Mesenchymal Stem Cells in Metabolic-Associated Fatty Liver Disease

Metabolic-associated fatty liver disease (MAFLD) is currently the most common chronic liver disease worldwide. However, its pathophysiological mechanism is complicated, and currently, it has no FDA-approved pharmacological therapies. In recent years, mesenchymal stem cell (MSC) therapy has attracted...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Sitong, Cong, Qingwei, Zhu, Ying, Xu, Qiumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839417/
https://www.ncbi.nlm.nih.gov/pubmed/36644008
http://dx.doi.org/10.1155/2023/3919002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839417/
https://www.ncbi.nlm.nih.gov/pubmed/36644008
http://dx.doi.org/10.1155/2023/3919002

Ejemplares similares